Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients ≥65 Years of Age Not Eligible for Intensive Chemotherapy

NCT02446145 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT02446145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02446145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients ≥65 Years of Age Not Eligible for Intensive Chemotherapy
Lead sponsor
Technische Universität Dresden
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2015
Completion date
January 25, 2023
Enrollment
132 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia